Gynecologic Cancers in China
Overview
Gynecologic cancers affect the cervix, uterus or ovaries. Each follows a distinct pathway — screening-driven for cervical, surgery-centered for endometrial and multimodal for ovarian disease — and outcomes improve markedly at centers treating these cancers routinely.
Chinese gynecologic oncology programs combine minimally invasive surgery, fertility-sparing options for young patients and intraperitoneal chemotherapy techniques for advanced ovarian cancer.
Symptoms & Signs
Abnormal vaginal bleeding — between periods, after intercourse or after menopause
Unusual vaginal discharge, sometimes blood-tinged
Bloating, early satiety and pelvic or abdominal pain, often late signs of ovarian cancer
Urinary urgency or frequency from pelvic mass effect
Pain during intercourse in cervical disease
Cervical screening detects pre-cancerous changes long before symptoms develop
Diagnosis
HPV testing and cytology with colposcopy-directed biopsy for cervical lesions
Pelvic ultrasound as the first imaging test for uterine and ovarian masses
Pelvic MRI defining tumor extent for surgical planning
Endometrial sampling (biopsy or hysteroscopy) for abnormal bleeding
CA-125 and HE4 tumor markers supporting ovarian-cancer assessment
Surgical-pathologic staging including frozen-section analysis during operations
Treatment Options
Fertility-sparing surgery (conization or trachelectomy) for selected young cervical-cancer patients
Radical hysterectomy with sentinel lymph node mapping
Minimally invasive laparoscopic or robotic staging for endometrial cancer
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) for selected ovarian cancer
Concurrent chemoradiation for locally advanced cervical cancer
PARP-inhibitor maintenance therapy and anti-angiogenic agents for ovarian cancer
Advanced Technologies & Novel Drug
Robotic and laparoscopic surgical platforms with sentinel node mapping
Image-guided adaptive brachytherapy for cervical cancer
HIPEC hyperthermic intraperitoneal chemotherapy systems
Frozen-section pathology enabling same-operation staging decisions
Novel PARP inhibitors and immunotherapy for recurrent disease
Hospital & Specialist
- Cancer Hospital, Chinese Academy of Medical Sciences (CICAMS) — Beijing
- Sun Yat-sen University Cancer Center (SYSUCC) — Guangzhou
- Fudan University Shanghai Cancer Center (FUSCC) — Shanghai
- The Obstetrics and Gynecology Hospital of Fudan University (Red House Hospital) — Shanghai
- Qu Peng Peng — Gynecologic Oncology
- Xiang Yang — Gynecologic Oncology
- Wan Xi Run — Gynecologic Oncology
- Pan Ling Ya — Gynecologic Oncology